The role of C1 inhibitor and complement as acute phase reactants: are we missing the diagnosis of hereditary angioedema?

Abstract Background C1 inhibitor (C1-INH) and complement 4 (C4) have historically been referred to as positive acute phase reactants, however this has never been evaluated in hereditary angioedema (HAE) patients. Low function of C1-INH and low levels of C4 are important in the diagnosis of HAE type...

Full description

Bibliographic Details
Main Authors: Peter Stepaniuk, Ana-Maria Bosonea, Persia Pourshahnazari, Adrienne Roos, Amin Kanani
Format: Article
Language:English
Published: BMC 2021-10-01
Series:Allergy, Asthma & Clinical Immunology
Subjects:
Online Access:https://doi.org/10.1186/s13223-021-00607-5
_version_ 1818404495599599616
author Peter Stepaniuk
Ana-Maria Bosonea
Persia Pourshahnazari
Adrienne Roos
Amin Kanani
author_facet Peter Stepaniuk
Ana-Maria Bosonea
Persia Pourshahnazari
Adrienne Roos
Amin Kanani
author_sort Peter Stepaniuk
collection DOAJ
description Abstract Background C1 inhibitor (C1-INH) and complement 4 (C4) have historically been referred to as positive acute phase reactants, however this has never been evaluated in hereditary angioedema (HAE) patients. Low function of C1-INH and low levels of C4 are important in the diagnosis of HAE type 1 and 2. If C1-INH and/or C4 are significant acute phase reactants, their levels may be falsely “normal” in patients with HAE when measured during times of infection or inflammation resulting in missed or delayed diagnosis. Case presentation We present a case series of four HAE patients who had C4, C1-INH, c-reactive protein (CRP) and ferritin measured at baseline and again during a self-reported upper respiratory tract infection (URTI) or flu-like illness. We did not identify any HAE patients who had a significant change in their C1-INH functional level in the context of a mild infection. However, the C4 level did increase into the normal range on three occasions (2 patients, with 1 patient having elevation during two separate illnesses). Conclusions C1 inhibitor may not be a clinically significant acute phase protein and appears to still be a reliable diagnostic marker of hereditary angioedema, even in times of modest acute inflammation, unlike complement C4 which can be elevated in this setting.
first_indexed 2024-12-14T08:41:04Z
format Article
id doaj.art-1ce021a0dc7a4717adee56371291ecea
institution Directory Open Access Journal
issn 1710-1492
language English
last_indexed 2024-12-14T08:41:04Z
publishDate 2021-10-01
publisher BMC
record_format Article
series Allergy, Asthma & Clinical Immunology
spelling doaj.art-1ce021a0dc7a4717adee56371291ecea2022-12-21T23:09:18ZengBMCAllergy, Asthma & Clinical Immunology1710-14922021-10-011711410.1186/s13223-021-00607-5The role of C1 inhibitor and complement as acute phase reactants: are we missing the diagnosis of hereditary angioedema?Peter Stepaniuk0Ana-Maria Bosonea1Persia Pourshahnazari2Adrienne Roos3Amin Kanani4Division of Allergy and Immunology, Department of Medicine, University of British ColumbiaAllergy and Immunology, Internal MedicineDivision of Allergy and Immunology, Department of Medicine, University of British ColumbiaDivision of Hematology/BMT, Department of Medicine, University of British ColumbiaDivision of Allergy and Immunology, Department of Medicine, University of British ColumbiaAbstract Background C1 inhibitor (C1-INH) and complement 4 (C4) have historically been referred to as positive acute phase reactants, however this has never been evaluated in hereditary angioedema (HAE) patients. Low function of C1-INH and low levels of C4 are important in the diagnosis of HAE type 1 and 2. If C1-INH and/or C4 are significant acute phase reactants, their levels may be falsely “normal” in patients with HAE when measured during times of infection or inflammation resulting in missed or delayed diagnosis. Case presentation We present a case series of four HAE patients who had C4, C1-INH, c-reactive protein (CRP) and ferritin measured at baseline and again during a self-reported upper respiratory tract infection (URTI) or flu-like illness. We did not identify any HAE patients who had a significant change in their C1-INH functional level in the context of a mild infection. However, the C4 level did increase into the normal range on three occasions (2 patients, with 1 patient having elevation during two separate illnesses). Conclusions C1 inhibitor may not be a clinically significant acute phase protein and appears to still be a reliable diagnostic marker of hereditary angioedema, even in times of modest acute inflammation, unlike complement C4 which can be elevated in this setting.https://doi.org/10.1186/s13223-021-00607-5Hereditary angioedemaAcute phaseC1 inhibitorC4ReactantInfection
spellingShingle Peter Stepaniuk
Ana-Maria Bosonea
Persia Pourshahnazari
Adrienne Roos
Amin Kanani
The role of C1 inhibitor and complement as acute phase reactants: are we missing the diagnosis of hereditary angioedema?
Allergy, Asthma & Clinical Immunology
Hereditary angioedema
Acute phase
C1 inhibitor
C4
Reactant
Infection
title The role of C1 inhibitor and complement as acute phase reactants: are we missing the diagnosis of hereditary angioedema?
title_full The role of C1 inhibitor and complement as acute phase reactants: are we missing the diagnosis of hereditary angioedema?
title_fullStr The role of C1 inhibitor and complement as acute phase reactants: are we missing the diagnosis of hereditary angioedema?
title_full_unstemmed The role of C1 inhibitor and complement as acute phase reactants: are we missing the diagnosis of hereditary angioedema?
title_short The role of C1 inhibitor and complement as acute phase reactants: are we missing the diagnosis of hereditary angioedema?
title_sort role of c1 inhibitor and complement as acute phase reactants are we missing the diagnosis of hereditary angioedema
topic Hereditary angioedema
Acute phase
C1 inhibitor
C4
Reactant
Infection
url https://doi.org/10.1186/s13223-021-00607-5
work_keys_str_mv AT peterstepaniuk theroleofc1inhibitorandcomplementasacutephasereactantsarewemissingthediagnosisofhereditaryangioedema
AT anamariabosonea theroleofc1inhibitorandcomplementasacutephasereactantsarewemissingthediagnosisofhereditaryangioedema
AT persiapourshahnazari theroleofc1inhibitorandcomplementasacutephasereactantsarewemissingthediagnosisofhereditaryangioedema
AT adrienneroos theroleofc1inhibitorandcomplementasacutephasereactantsarewemissingthediagnosisofhereditaryangioedema
AT aminkanani theroleofc1inhibitorandcomplementasacutephasereactantsarewemissingthediagnosisofhereditaryangioedema
AT peterstepaniuk roleofc1inhibitorandcomplementasacutephasereactantsarewemissingthediagnosisofhereditaryangioedema
AT anamariabosonea roleofc1inhibitorandcomplementasacutephasereactantsarewemissingthediagnosisofhereditaryangioedema
AT persiapourshahnazari roleofc1inhibitorandcomplementasacutephasereactantsarewemissingthediagnosisofhereditaryangioedema
AT adrienneroos roleofc1inhibitorandcomplementasacutephasereactantsarewemissingthediagnosisofhereditaryangioedema
AT aminkanani roleofc1inhibitorandcomplementasacutephasereactantsarewemissingthediagnosisofhereditaryangioedema